Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.